ALGOQUANT vs NIVABUPA: Stock Comparison
NIVA BUPA HEALTH INS CO L is the larger company by market capitalisation. ALGOQUANT FINTECH shows a lower P/E, a higher ROE and a higher ROCE, while NIVA BUPA HEALTH INS CO L shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ALGOQUANT leads 4; NIVABUPA leads 4 of 9
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ALGOQUANT | NIVABUPA |
|---|---|---|
| Sector | — | Financial Services |
| Industry | — | General Insurance |
Price
| Metric | ALGOQUANT | NIVABUPA |
|---|---|---|
| Live Price | ₹63.8 | ₹80.73 |
| Day Change | 1.24% | -1.91% |
| Volume | 13.29 L | 3.66 L |
| 52-Week High | ₹71.01 | ₹91.4 |
| 52-Week Low | ₹47.8 | ₹67.5 |
| Distance from 52W High | -10.15% | -11.67% |
Valuation
| Metric | ALGOQUANT | NIVABUPA |
|---|---|---|
| Market Cap | ₹1,796 Cr | ₹14,923 Cr |
| P/E Ratio | 39.66x | 116.18x |
| P/B Ratio | 13.44x | 4x |
| EPS | ₹0.59 | ₹1.87 |
| Book Value | ₹4.78 | ₹23.73 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | ALGOQUANT | NIVABUPA |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 26.8% |
| EPS Growth (TTM YoY) | 0% | 90.2% |
| Qtr Sales Growth | 0% | — |
| Qtr Profit Growth | 0% | — |
Profitability & Leverage
Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.| Metric | ALGOQUANT | NIVABUPA |
|---|---|---|
| ROE | 24.84% | 0% |
| ROCE | 34.33% | 0% |
| Net Margin | 14.18% | 4.34% |
| Operating Margin | 20.62% | — |
| Debt to Equity | 0.23x | 0.07x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ALGOQUANT | NIVABUPA |
|---|---|---|
| Promoter Holding | 73.68% | 0% |
| FII Holding | 0.81%▼ 0.41 pp | 12.09%▲ 1.49 pp |
| DII Holding | 0.09%▲ 0.07 pp | 16.17%▼ 0.32 pp |
| Public Holding | 22.02%▲ 0.34 pp | 16.44%▼ 1.11 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALGOQUANT FINTECH and NIVA BUPA HEALTH INS CO L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.